- 4 次围观
产品图片

货号/SKU
NR-45894
货号/规格
EA
库存与交货期
3-8周
人民币价格
14000
试剂海关审批
A/B级风险物质只能直接使用人购买并持有实验室有效资质,其它询客服确认
国外采购
支持/部分限制一年内购买数量
厂牌
BEI Resources(ATCC)
产品基础信息
生物安全等级建议分类:美国、2
产品描述信息
NR-45894??Staphylococcus aureus, LY-1999 0620-02(Bacteria)|Staphylococcus aureus|LY-1999 0620-02|-60°C or colder|NARSAAcknowledgment for publications should read “The following reagent was provided by the Network on Antimicrobial Resistance in Staphylococcus aureus (NARSA) for distribution by BEI Resources, NIAID, NIH: Staphylococcus aureus, Strain LY-1999 0620-02, NR-45894.”|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
Staphylococcus aureus (S. aureus), strain LY-1999 0620-02 (also referred to as NRS64) was isolated in Oman in 1998 from blood of a 50-year-old female patient with septicemia who had a history of diabetes mellitus, chronic renal failure, renal transplant with subsequent rejection, wound and catheter infections and extended treatment with glycopeptides.
S. aureus, strain LY-1999 0620-02 is a glycopeptide-sensitive S. aureus (GSSA) strain. S. aureus, strain LY-1999 0620-02 was deposited as positive for mec (subtype III); negative for vanA, vanB, vanC1, vanC2, vanD and vanE; MLST sequencing type (ST) 372; eGenomic spa type 3, eGenomic spa repeats WGKAOMQ; Ridom spa type t037. Strain LY-1999 0620-02 and strain LY-1999 0620-03 (NRS65) were isolated on the same day from the patient and are related by pulsed-field gel electrophoresis (PFGE).
Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.
Staphylococcus aureus (S. aureus), strain LY-1999 0620-02 (also referred to as NRS64) was isolated in Oman in 1998 from blood of a 50-year-old female patient with septicemia who had a history of diabetes mellitus, chronic renal failure, renal transplant with subsequent rejection, wound and catheter infections and extended treatment with glycopeptides.
S. aureus, strain LY-1999 0620-02 is a glycopeptide-sensitive S. aureus (GSSA) strain. S. aureus, strain LY-1999 0620-02 was deposited as positive for mec (subtype III); negative for vanA, vanB, vanC1, vanC2, vanD and vanE; MLST sequencing type (ST) 372; eGenomic spa type 3, eGenomic spa repeats WGKAOMQ; Ridom spa type t037. Strain LY-1999 0620-02 and strain LY-1999 0620-03 (NRS65) were isolated on the same day from the patient and are related by pulsed-field gel electrophoresis (PFGE).
Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.
主要内容
此项目的每个订单数量限制为1.此商品每年可订购两次.通过此限制的订单将在发货前发送到NIAID进行批准. 葡萄球菌
金黄色葡萄球菌( s.aureus ),Ly-1999
1998年从一个50岁女性患者的血液中孤立0620-02(也称为NRS64).
患有糖尿病史的败血症,慢性肾功能衰竭,
随后的排斥,伤口和导管感染和导管感染肾移植
用糖肽进行延长治疗. S.金黄色葡萄球菌,
菌株Ly-1999 0620-02是一种糖肽敏感性
s.金黄色葡萄球菌(GSSA)应变.    s.金黄色葡萄球菌,LY-1999
将0620-02沉积为 MEC (亚型III)阳性; vana 负面,
Vanb , Vanc1, Vanc2 , vand 和 vane ; MLST测序类型(ST)372; egenomic.
spa 3型,egenomic spa 重复wgkaomq; ridom spa type t037型.   菌株 ly-1999 0620-02和strature ly-1999 0620-03(nrs65)
在患者的同一天被隔绝,并与脉冲场相关
凝胶电泳(PFGE). 含有10%甘油的胰蛋白酶大豆肉汤中的约0.5毫升细菌培养物.
厂牌介绍
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立,旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中,可以监控科学界对这些材料的访问和使用,并确保试剂的质量控制。
除了为传染病界提供材料外,BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势,包括安全存储、社区访问和分发;同时保护存款人的知识产权。只要有需要,BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月, ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料,包括由其他政府支持的研究项目存放的材料,将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中,涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。
品牌标识

可能感兴趣的内容
2022-04-01
2024-01-21
2021-10-31
2019-05-08
2022-04-01
2021-12-21
2022-04-01
2022-04-01
2021-12-21
2022-06-17
2021-12-21
2024-01-21
2024-01-21
2023-11-12
2024-05-19